Smith & Nephew has launched the HEALICOIL REGENESORB suture anchor made out of advanced biocomposite material for use in arthroscopic surgery. HEALICOIL REGENESORB not only uses the osteoconductive properties of beta tricalcium phosphate (β-TCP) to provide 18 months of sustained bone formation like other biocomposite implants but also utilizes a second osteoconductive component, calcium sulfate, that comes into play early in the bone healing process and helps to increase the levels of local growth factors.
Unlike solid core implants, the HEALICOIL suture anchor has an open-architecture that eliminates the material between the anchor threads and allows blood and bone marrow from surrounding cancellous bone to enter the implant in about 12 weeks post implantation. The open architecture also results in lesser implant material at the site of reconstruction, allowing for an easier revision process if necessary. The reduced volume of material does not compromise the torsional strength, fixation or pullout strength of the anchor.
The HEALICOIL Suture Anchor is engineered to hold fixation throughout the healing period in sub-optimal quality bone and is able to withstand normal shoulder loading forces and typical range of motion experienced during physical therapy or rehabilitation.
Video showing insertion of the HEALICOIL Suture Anchor:
Press release: Smith & Nephew Introduces Advanced Biocomposite Material for Use in Arthroscopic Surgery…
Product page: HEALICOIL Suture Anchor…
